Engaging hospitalized heroin-dependent patients into substance abuse treatment.
The purpose of this study was to evaluate a 6-month outpatient program developed to improve abstinence and other health and social problems of heroin-addicted persons hospitalized in an urban academic medical center's medical or surgical unit and referred from the Substance Abuse Consult Service. Treatment intervention consisted of methadone therapy, daily group therapy, individual case management, medical and psychiatric consultation, and social services. The first 67 patients referred were followed for 6 months. Outcome measures were retention in treatment, urine drug screens, and health and social indicators. Patients averaged 19 weeks in treatment, with 52% of patients completing the 6-month program. Urine toxicology screens showed a reduction of illicit drug use. Patients improved deficits in health and social indicators by obtaining medical coverage, keeping outpatient medical appointments, and improving their housing conditions. Findings suggest that this combination of intensive psychosocial treatment with opioid substitution following an acute illness substantially impacts treatment outcomes. Implications for service delivery and health-care economics are discussed.
Aszalos
R
R
Department of Family Medicine, University of Maryland School of Medicine, Baltimore, USA. raszalos@aol.com
McDuff
D R
DR
Weintraub
E
E
Montoya
I
I
Schwartz
R
R
D000293:Adolescent; D000328:Adult; D000553:Ambulatory Care; D005260:Female; D006556:Heroin Dependence / Q000150:complications / Q000628:therapy*; D006760:Hospitalization; D006801:Humans; D008297:Male; D008691:Methadone / Q000008:administration & dosage*; D008875:Middle Aged; D009294:Narcotics / Q000008:administration & dosage*; D017063:Outcome Assessment, Health Care; D010349:Patient Compliance; D015397:Program Evaluation; D011613:Psychotherapy / Q000379:methods*; D015813:Substance Abuse Detection; D016320:Substance Abuse Treatment Centers / Q000458:organization & administration*
D009294:Narcotics; D008691:Methadone